MUFG Rings Closing Bell® at New York Stock Exchange

Event Marks 20th Anniversary of Merger Between Mitsubishi Tokyo Financial Group, UFJ Holdings to form MUFG NEW YORK, Nov. 25, 2025 /PRNewswire/ — Mitsubishi UFJ Financial Group (NYSE: MUFG), one of the 10 largest global financial groups, rang The Closing Bell® at the New York Stock Exchange today to commemorate the 20th anniversary of the merger… Continue reading MUFG Rings Closing Bell® at New York Stock Exchange

Korea Innovation Foundation selects 2 Innovative AI/IoT companies, C&TECH, and BeringLab for Global Technology Commercialization Support Program (North America)

DAEJEON, South Korea, Nov. 25, 2025 /PRNewswire/ — Korea Innovation Foundation (INNOPOLIS), currently operating the 2025 Global Technology Commercialization Support Program (North America), announces that 2 innovative companies, C&TECH, and BeringLab are chosen for the support program. Continue Reading C&TECH – Smart IoT Asset Management System BeringLab – AI Powered Legal and Patent Translation This… Continue reading Korea Innovation Foundation selects 2 Innovative AI/IoT companies, C&TECH, and BeringLab for Global Technology Commercialization Support Program (North America)

LINGLONG TIRE TIPS OFF NEW JOURNEY WITH CHICAGO BULLS

Partnership underscores Chicago Bulls’ global reach and resonance and reflects Linglong Tire’s efforts to continue growing sports marketing portfolio CHICAGO, Nov. 25, 2025 /PRNewswire/ — On November 25, 2025, Linglong Tire announced a global partnership with the NBA’s world-renowned Chicago Bulls. This signing marks another significant move by Linglong Tire in the field of sports marketing… Continue reading LINGLONG TIRE TIPS OFF NEW JOURNEY WITH CHICAGO BULLS

CPTN Deadline: CPTN Investors Have Opportunity to Lead Cepton, Inc. Securities Fraud Lawsuit

NEW YORK, Nov. 25, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of common stock of Cepton, Inc. (NASDAQ: CPTN) between July 29, 2024 and January 6, 2025, both dates inclusive (the “Class Period”), of the important December 8, 2025 lead plaintiff deadline. So what: If… Continue reading CPTN Deadline: CPTN Investors Have Opportunity to Lead Cepton, Inc. Securities Fraud Lawsuit

BAX Deadline: BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit

NEW YORK, Nov. 25, 2025 /PRNewswire/ —  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Baxter International Inc. (NYSE: BAX) between February 23, 2022 and July 30, 2025, both dates inclusive (the “Class Period”), of the important December 15, 2025 lead plaintiff deadline. So what: If you purchased… Continue reading BAX Deadline: BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit

GOLD ROYALTY ANNOUNCES AMENDED AND UPSIZED REVOLVING CREDIT FACILITY OF UP TO US$100 MILLION AND ELIMINATION OF DEBT

Retirement of long-term fixed interest convertible debentures and upsized credit facility with lower cost of borrowing enhance Gold Royalty’s cash flow profile and strengthen the balance sheet to support continued growth  VANCOUVER, BC, Nov. 25, 2025 /PRNewswire/ – Gold Royalty Corp. (“Gold Royalty” or the “Company“) (NYSE American: GROY) is pleased to announce that it has… Continue reading GOLD ROYALTY ANNOUNCES AMENDED AND UPSIZED REVOLVING CREDIT FACILITY OF UP TO US$100 MILLION AND ELIMINATION OF DEBT

Prestige Biopharma and Biosidus Enter Exclusive License Agreement for Tuznue® Commercialization in Latin America

SINGAPORE, Nov. 26, 2025 /PRNewswire/ — Prestige Biopharma, a biopharmaceutical company specializing in antibody therapeutics, today announced an exclusive license and supply agreement with Biosidus, a biotechnology company headquartered in Buenos Aires, Argentina, with decades of experience in biosimilar development and commercialization, for the commercialization of Tuznue® (trastuzumab) across Latin American markets, including Argentina, Mexico, Bolivia,… Continue reading Prestige Biopharma and Biosidus Enter Exclusive License Agreement for Tuznue® Commercialization in Latin America

PRIVACY ALERT: Delta Dental of Virginia Under Investigation for Data Breach of 145,918 Records

SAN FRANCISCO, Nov. 25, 2025 /PRNewswire/ — Schubert Jonckheer & Kolbe LLP is investigating a data breach that led to unauthorized access to the sensitive information of 145,918 individuals affiliated with Delta Dental of Virginia, which is the largest dental benefits provider in Virginia. On April 23, 2025, Delta Dental of Virginia detected unusual activity associated with… Continue reading PRIVACY ALERT: Delta Dental of Virginia Under Investigation for Data Breach of 145,918 Records

Primo Brands Corporation (PRMB) Faces Securities Class Action Amid Botched Integration, CEO Departure — Hagens Berman

PRMB Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, Nov. 25, 2025 /PRNewswire/ — A securities class action lawsuit has been filed against beverage company Primo Brands Corporation (NYSE: PRMB) in the wake of its troubled merger with BlueTriton Brands. The suit seeks to represent investors who purchased or otherwise acquired the common stock… Continue reading Primo Brands Corporation (PRMB) Faces Securities Class Action Amid Botched Integration, CEO Departure — Hagens Berman

Telix Pharmaceuticals (TLX) Hit with Investor Lawsuit Alleging Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability– Hagens Berman

SAN FRANCISCO, Nov. 25, 2025 /PRNewswire/ –Telix Pharmaceuticals Ltd. (NASDAQ: TLX), a commercial-stage biopharmaceutical company specializing in diagnostic and therapeutic radiopharmaceuticals, is now the target of a securities class action lawsuit following a series of regulatory setbacks and steep stock declines over the summer. Hagens Berman is actively investigating the allegations and urges Telix investors… Continue reading Telix Pharmaceuticals (TLX) Hit with Investor Lawsuit Alleging Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability– Hagens Berman